Get started
Author

Nami Mori

Observed names: Mori Nami, NAMI MORI, Nami MORI
ORCID: 0000-0001-8589-6560
Observed ORCID: 0000-0001-8589-6560
OpenAlex ID: A5102143879
Emergence of a Novel Lamivudine-Resistant Hepatitis B Virus Variant with a Substitution Outside the YMDD Motif
2006 · Hiromi Yatsuji, Chiemi Noguchi, et al. · Antimicrobial Agents and Chemotherapy · 71
Dual effect of APOBEC3G on Hepatitis B virus
2007 · Chiemi Noguchi, Nobuhiko Hiraga, et al. · Journal of General Virology · 69
Serum HBV RNA is a predictor of early emergence of the YMDD mutant in patients treated with lamivudine†
2007 · Tsuyoshi Hatakeyama, Chiemi Noguchi, et al. · Hepatology · 68
Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan
2017 · Goki Suda, Norihiro Furusyo, et al. · Journal of Gastroenterology · 56
Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma
2021 · Yuwa Ando, Tomokazu Kawaoka, et al. · Oncology · 55
Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection
2020 · Xiaoming Cheng, Takuro Uchida, et al. · Journal of Clinical Investigation · 52
PDF
Usefulness of neutrophil‐to‐lymphocyte ratio in predicting progression and survival outcomes after atezolizumab–bevacizumab treatment for hepatocellular carcinoma
2022 · Hironori Ochi, Masayuki Kurosaki, et al. · Hepatology Research · 49
PDF
Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis
2018 · Kenichiro Kodama, Tomokazu Kawaoka, et al. · Oncology · 46
Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus
2020 · Nobuharu Tamaki, Masayuki Kurosaki, et al. · Clinical Infectious Diseases · 45
PDF
Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group
2018 · Keiji Tsuji, Masayuki Kurosaki, et al. · Journal of Gastroenterology · 45
Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status
2018 · Kenichiro Kodama, Tomokazu Kawaoka, et al. · Journal of Gastroenterology and Hepatology · 39
Establishment of an infectious genotype 1b hepatitis C virus clone in human hepatocyte chimeric mice
2008 · Takashi Kimura, Michio Imamura, et al. · Journal of General Virology · 37
A case of drug-induced liver injury with prolonged severe intrahepatic cholestasis induced by Ashwagandha
2017 · Katsuaki Inagaki, Nami Mori, et al. · Kanzo · 36
PDF
Successful treatment of an entecavir‐resistant hepatitis B virus variant
2007 · Hiromi Yatsuji, Nobuhiko Hiraga, et al. · Journal of Medical Virology · 35
Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy and Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization.
2016 · Masahiro Hatooka, Tomokazu Kawaoka, et al. · PubMed · 32
Real‐world clinical outcomes of sofosbuvir and velpatasvir treatment in HCV genotype 1‐ and 2‐infected patients with decompensated cirrhosis: A nationwide multicenter study by the Japanese Red Cross Liver Study Group
2021 · Toshifumi Tada, Masayuki Kurosaki, et al. · Journal of Medical Virology · 30
Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib
2020 · Yuwa Ando, Tomokazu Kawaoka, et al. · Oncology · 30
Randomized trial of high‐dose interferon‐α‐2b combined with ribavirin in patients with chronic hepatitis C: Correlation between amino acid substitutions in the core/NS5A region and virological response to interferon therapy
2009 · Nami Mori, Michio Imamura, et al. · Journal of Medical Virology · 28
Determinants of the clinical outcome of patients with severe acute exacerbation of chronic hepatitis B virus infection
2012 · Nami Mori, Fumitaka Suzuki, et al. · Journal of Gastroenterology · 25
Efficacy of Percutaneous Cementoplasty for Bone Metastasis from Hepatocellular Carcinoma
2007 · Hideaki Kodama, Hiroshi Aikata, et al. · Oncology · 25
G‐to‐A Hypermutation in Hepatitis B Virus (HBV) and Clinical Course of Patients with Chronic HBV Infection
2009 · Chiemi Noguchi, Michio Imamura, et al. · The Journal of Infectious Diseases · 24
Combination Therapy of Oral Fluoropyrimidine Anticancer Drug S-1 and Interferon Alpha for HCC Patients with Extrahepatic Metastases
2008 · Kiminori Uka, Hiroshi Aikata, et al. · Oncology · 24
Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma
2023 · Shigeki Yano, Tomokazu Kawaoka, et al. · Cancers · 21
PDF
Effects on survival of the adverse event of atezolizumab plus bevacizumab for hepatocellular carcinoma: a multicenter study by the Japan Red Cross Liver Study Group
2023 · Shintaro Takaki, Masayuki Kurosaki, et al. · Investigational New Drugs · 21
Efficacy of vonoprazan 10 mg compared with 20 mg for the initial treatment in patients with erosive esophagitis: a randomized pilot study
2020 · Hideharu Okanobu, Tomohiko Kohno, et al. · Esophagus · 20
Works count: 90
Citation count: 1,318
H-index: 22
I10-index: 39
Year
Topic
Type